• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用镓-PSMA PET/CT的放射生物学参数评估前列腺主要病灶中的剂量描绘。

Evaluation of Dose-Painting in the Dominant Intraprostatic Lesions by Radiobiological Parameters using Ga- PSMA PET/CT.

作者信息

Bamneshin Khadijeh, Rabi Mahdavi Seied, Bitarafan-Rajabi Ahmad, Geramifar Parham, Hejazi Payman, Koosha Fereshteh, Jadidi Majid

机构信息

PhD, Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

PhD, Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.

出版信息

J Biomed Phys Eng. 2022 Aug 1;12(4):369-376. doi: 10.31661/jbpe.v0i0.1912-1006. eCollection 2022 Aug.

DOI:10.31661/jbpe.v0i0.1912-1006
PMID:36059285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9395631/
Abstract

BACKGROUND

Patients diagnosed with dominant intraprostatic lesions (DIL) may need radiation doses over than 80 Gy. Dose-painting by contours (DPC) is a useful technique which helps the patients. Dose-painting approach need to be evaluated.

OBJECTIVE

To evaluate the DCP technique in the case of boosting the DILs by radiobiological parameters, tumor control probability (TCP), and normal tissue complication probability (NTCP) via PET/CT images traced by Ga-PSMA.

MATERIAL AND METHODS

In this analytical study, Ga-PSMA PET/CT images were obtained from patients with DILs that were delineated using the Fuzzy c-mean (FCM) algorithm and thresholding methods. The protocol of therapy included two phases; at the first phase (ph1), a total dose of 72 Gy in 36 fractions were delivered to the planning target volume (PTV1); the seconds phase consisted of the application of variable doses to the PTV2. Moreover, two concepts were also considered to calculate the TCP using the Zaider-Minerbo model.

RESULTS

The lowest volume in DILs belonged to the DIL1 extracted by the FCM method. According to dose-volume parameters of the rectum and bladder, by the increase in the PTV dose higher than 92 Gy, the amounts of rectum and bladder doses are increased. There was no difference between the TCPs of DILs at doses higher than 86 Gy and 100 Gy for ordinary and high clone density, respectively.

CONCLUSION

Consequently, our dose-painting approach for DILs, extracted by the FCM method via PET/CT images, can reduce the total dose for prostate radiation with 100% tumor control and less normal tissue complications.

摘要

背景

被诊断为前列腺内显性病变(DIL)的患者可能需要超过80 Gy的辐射剂量。轮廓剂量描绘(DPC)是一种对患者有帮助的有用技术。需要对剂量描绘方法进行评估。

目的

通过Ga-PSMA追踪的PET/CT图像,利用放射生物学参数、肿瘤控制概率(TCP)和正常组织并发症概率(NTCP)来评估DCP技术在增强DIL方面的应用。

材料与方法

在这项分析研究中,从患有DIL的患者获取Ga-PSMA PET/CT图像,这些图像使用模糊c均值(FCM)算法和阈值方法进行勾勒。治疗方案包括两个阶段;在第一阶段(ph1),向计划靶体积(PTV1)给予36次分割的总剂量72 Gy;第二阶段包括向PTV2施加可变剂量。此外,还考虑了两个概念,使用Zaider-Minerbo模型计算TCP。

结果

DIL中体积最小的是通过FCM方法提取的DIL1。根据直肠和膀胱的剂量体积参数,当PTV剂量增加到高于92 Gy时,直肠和膀胱的剂量会增加。对于普通克隆密度和高克隆密度,分别在高于86 Gy和100 Gy的剂量下,DIL的TCP之间没有差异。

结论

因此,我们通过PET/CT图像利用FCM方法提取的针对DIL的剂量描绘方法,可以在实现100%肿瘤控制且减少正常组织并发症的情况下降低前列腺放疗的总剂量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a4/9395631/8ee184e07fd7/JBPE-12-369-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a4/9395631/20d6a1651417/JBPE-12-369-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a4/9395631/72538705985d/JBPE-12-369-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a4/9395631/f6af0d0389c2/JBPE-12-369-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a4/9395631/8ee184e07fd7/JBPE-12-369-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a4/9395631/20d6a1651417/JBPE-12-369-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a4/9395631/72538705985d/JBPE-12-369-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a4/9395631/f6af0d0389c2/JBPE-12-369-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a4/9395631/8ee184e07fd7/JBPE-12-369-g004.jpg

相似文献

1
Evaluation of Dose-Painting in the Dominant Intraprostatic Lesions by Radiobiological Parameters using Ga- PSMA PET/CT.利用镓-PSMA PET/CT的放射生物学参数评估前列腺主要病灶中的剂量描绘。
J Biomed Phys Eng. 2022 Aug 1;12(4):369-376. doi: 10.31661/jbpe.v0i0.1912-1006. eCollection 2022 Aug.
2
Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesions.应用容积旋转调强弧形放疗治疗前列腺内优势肿瘤病灶的前列腺立体定向消融放疗。
Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):406-15. doi: 10.1016/j.ijrobp.2014.01.042. Epub 2014 Mar 28.
3
Focal dose escalation for prostate cancer using Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference.基于组织学参考的 Ga-HBED-CC PSMA PET/CT 和 MRI 引导前列腺癌焦点剂量递增:一项计划研究。
Radiat Oncol. 2018 May 2;13(1):81. doi: 10.1186/s13014-018-1036-8.
4
Proton versus photon therapy for high-risk prostate cancer with dose escalation of dominant intraprostatic lesions: a preliminary planning study.针对高危前列腺癌伴主要前列腺内病灶剂量递增的质子治疗与光子治疗:一项初步计划研究。
Front Oncol. 2023 Nov 8;13:1241711. doi: 10.3389/fonc.2023.1241711. eCollection 2023.
5
Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using Ga-HBED-CC PSMA-PET/CT: A planning study based on histopathology reference.基于组织病理学参考的 Ga-HBED-CC PSMA-PET/CT 评估局部前列腺癌调强放疗剂量绘画:一项计划研究。
Radiother Oncol. 2017 Jun;123(3):472-477. doi: 10.1016/j.radonc.2017.04.021. Epub 2017 May 9.
6
Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts.PSMA PET 勾画的前列腺内主要病灶同步适形野加量的剂量学评估
Adv Radiat Oncol. 2019 Sep 27;5(2):212-220. doi: 10.1016/j.adro.2019.09.004. eCollection 2020 Mar-Apr.
7
Ga-PSMA-PET/CT imaging of localized primary prostate cancer patients for intensity modulated radiation therapy treatment planning with integrated boost.镓-PSMA-PET/CT 成像在局部前列腺癌患者中的应用,用于调强放射治疗的整合加量计划。
Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1170-1178. doi: 10.1007/s00259-018-3954-y. Epub 2018 Feb 21.
8
Effect of androgen deprivation therapy on intraprostatic tumour volume identified on F choline PET/CT for prostate dose painting radiotherapy.雄激素剥夺疗法对通过F胆碱PET/CT确定的前列腺内肿瘤体积的影响,用于前列腺剂量引导放疗。
Br J Radiol. 2017 Mar;90(1071):20160818. doi: 10.1259/bjr.20160818. Epub 2016 Dec 20.
9
Intensity modulated radiation therapy dose painting for localized prostate cancer using ¹¹C-choline positron emission tomography scans.¹¹C-胆碱正电子发射断层扫描在局限性前列腺癌调强放疗中的剂量描绘。
Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e691-6. doi: 10.1016/j.ijrobp.2012.01.087. Epub 2012 May 30.
10
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.

本文引用的文献

1
Multiparametric MRI-guided dose boost to dominant intraprostatic lesions in CT-based High-dose-rate prostate brachytherapy.基于CT的高剂量率前列腺近距离放射治疗中多参数MRI引导下对前列腺内主要病灶的剂量增强
Br J Radiol. 2019 May;92(1097):20190089. doi: 10.1259/bjr.20190089. Epub 2019 Apr 9.
2
Prognostic value of 68 Ga PSMA I&T PET/CT SUV parameters on survival outcome in advanced prostat cancer.
Ann Nucl Med. 2018 Oct;32(8):542-552. doi: 10.1007/s12149-018-1277-5. Epub 2018 Jul 13.
3
The dose distribution in dominant intraprostatic tumour lesions defined by multiparametric MRI and PSMA PET/CT correlates with the outcome in patients treated with primary radiation therapy for prostate cancer.由多参数MRI和PSMA PET/CT定义的前列腺内主要肿瘤病灶中的剂量分布与接受前列腺癌原发性放射治疗患者的预后相关。
Radiat Oncol. 2018 Apr 12;13(1):65. doi: 10.1186/s13014-018-1014-1.
4
The delineation of intraprostatic boost regions for radiotherapy using multimodality imaging.多模态影像在前列腺放疗内靶区勾画中的应用。
Future Oncol. 2016 Nov;12(21):2495-2511. doi: 10.2217/fon-2016-0129. Epub 2016 Jun 20.
5
PET guidance in prostate cancer radiotherapy: Quantitative imaging to predict response and guide treatment.
Phys Med. 2016 Mar;32(3):452-8. doi: 10.1016/j.ejmp.2016.02.013. Epub 2016 Apr 11.
6
RADBIOMOD: A simple program for utilising biological modelling in radiotherapy plan evaluation.RADBIOMOD:一个用于在放射治疗计划评估中利用生物建模的简单程序。
Phys Med. 2016 Jan;32(1):248-54. doi: 10.1016/j.ejmp.2015.10.091. Epub 2015 Nov 6.
7
Prostate Dose-painting Radiotherapy and Radiobiological Guided Optimisation Enhances the Therapeutic Ratio.前列腺剂量勾画放疗与放射生物学引导的优化提高了治疗比。
Clin Oncol (R Coll Radiol). 2016 Mar;28(3):165-70. doi: 10.1016/j.clon.2015.09.006. Epub 2015 Oct 21.
8
Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.多灶性前列腺癌的遗传系统发育分析确定了肿瘤性和形态学正常前列腺组织中的多个独立克隆扩增。
Nat Genet. 2015 Apr;47(4):367-372. doi: 10.1038/ng.3221. Epub 2015 Mar 2.
9
Boosting imaging defined dominant prostatic tumors: a systematic review.增强成像定义的主要前列腺肿瘤:系统评价。
Radiother Oncol. 2013 Jun;107(3):274-81. doi: 10.1016/j.radonc.2013.04.027. Epub 2013 Jun 20.
10
Biological optimization of simultaneous boost on intra-prostatic lesions (DILs): sensitivity to TCP parameters.针对前列腺内病灶(DILs)的同步推量的生物学优化:对 TCP 参数的敏感性。
Phys Med. 2013 Nov;29(6):592-8. doi: 10.1016/j.ejmp.2012.10.002. Epub 2012 Oct 25.